{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:42:24Z","timestamp":1765615344718,"version":"3.48.0"},"reference-count":7,"publisher":"BMJ","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gut"],"published-print":{"date-parts":[[1995,4]]},"DOI":"10.1136\/gut.36.4.640","type":"journal-article","created":{"date-parts":[[2007,9,18]],"date-time":"2007-09-18T17:41:31Z","timestamp":1190137291000},"page":"640.1-640","source":"Crossref","is-referenced-by-count":1,"title":["New salicylates as maintenance treatment in ulcerative colitis."],"prefix":"10.1136","volume":"36","author":[{"given":"C A","family":"Sninsky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[1995,4,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-115-5-350","article-title":"Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis","volume":"115","author":"Sninsky, C.A.; Cort, D.H.; Shannahan, F.; Powers, F.J.; Sessions, J.T.; Pruitt, R.E.","year":"1991","unstructured":"Sninsky CA, Cort DH, Shannahan F, Powers FJ, Sessions JT, Pruitt RE, et al. Oral mesalamine (Asacol) for mildly to moderately active ulcerative colitis. Ann Intern Med 1991; 115: 350-5.","journal-title":"Ann Intern Med"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"540","DOI":"10.7326\/0003-4819-118-7-199304010-00009","article-title":"Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis","volume":"118","author":"Sutherland, L.R.; May, G.R.; Shaffer, E.A.","year":"1993","unstructured":"Sutherland LR, May GR, Shaffer EA. Sulfasalazine revisited: a meta-analysis of 5-aminosalicylic acid in the treatment of ulcerative colitis. Ann Intern Med 1993; 118: 540-9.","journal-title":"Ann Intern Med"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/0140-6736(92)91601-4","article-title":"Randomized comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis","volume":"339","author":"Courtney, M.G.; Nunes, D.P.; Bergin, C.F.; O'Driscoll, M.; Trimble, V.; Keeling, P.W.N.","year":"1992","unstructured":"Courtney MG, Nunes DP, Bergin CF, O'Driscoll M, Trimble V, Keeling PWN, et al. Randomized comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet 1992; 339: 1279-81.","journal-title":"Lancet"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/0140-6736(92)91809-M","article-title":"Comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis","volume":"340","author":"Gait, J.E.; Simerl, N.A.","year":"1992","unstructured":"Gait JE, Simerl NA. Comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet 1992; 340: 486-7.","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/0140-6736(92)92656-Z","article-title":"Mesalazine versus olsalazine for prophylaxis of ulcerative colitis","volume":"340","author":"Record, C.O.; MaCrae, K.","year":"1992","unstructured":"Record CO, MaCrae K. Mesalazine versus olsalazine for prophylaxis of ulcerative colitis. Lancet 1992; 340: 1468.","journal-title":"Lancet"},{"key":"ref_6","article-title":"Sensitive markers of renal dysfunction are elevated in chronic ulcerative colitis. 10th Congress of Gastroenterology","author":"Sninsky, C.; Hanauer, S.; Powers, B.; Robinson, M.; Mayle, J.; Elson, C.","year":"1994","unstructured":"Sninsky C, Hanauer S, Powers B, Robinson M, Mayle J, Elson C, et al. Sensitive markers of renal dysfunction are elevated in chronic ulcerative colitis. 10th Congress of Gastroenterology, October 2-7, 1994. Los Angeles, CA: 1778."},{"key":"ref_7","first-page":"1279","article-title":"Randomized comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis","volume":"332","author":"Courtney, M.G.; Nunes, D.P.; Bergin, C.F.; O'Driscoll, M.; Trimble, V.; Keeling, P.W.N.","year":"1992","unstructured":"Courtney MG, Nunes DP, Bergin CF, O'Driscoll M, Trimble V, Keeling PWN, et al. Randomized comparison of olsalazine and mesalazine in prevention of relapses in ulcerative colitis. Lancet 1992; 332: 1279-81.","journal-title":"Lancet"}],"container-title":["Gut"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/gut.36.4.640","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T08:39:58Z","timestamp":1765615198000},"score":1,"resource":{"primary":{"URL":"https:\/\/gut.bmj.com\/lookup\/doi\/10.1136\/gut.36.4.640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,4]]},"references-count":7,"journal-issue":{"issue":"4","published-online":{"date-parts":[[1995,4,1]]},"published-print":{"date-parts":[[1995,4]]}},"alternative-id":["10.1136\/gut.36.4.640"],"URL":"https:\/\/doi.org\/10.1136\/gut.36.4.640","relation":{},"ISSN":["0017-5749","1468-3288"],"issn-type":[{"type":"print","value":"0017-5749"},{"type":"electronic","value":"1468-3288"}],"subject":[],"published":{"date-parts":[[1995,4]]}}}